Interim Guidance for Rapid Antigen Testing for SARS-CoV-2 | NLM

Disaster Information Management Research Center | NLM

Interim Guidance for Rapid Antigen Testing for SARS-CoV-2

08/16/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/16/2020. The purpose of this interim technical guidance is to support the most effective use of antigen tests for SARS-CoV-2 for different testing situations. It applies to all uses of antigen tests and is not specific to the application of antigen tests to any particular age group or setting. It is intended for clinicians who order antigen tests, receive antigen test results, and/or perform point-of-care testing, as well as for laboratory professionals who perform antigen testing in a laboratory setting or at the point of care and report those results. (Text)